In addition, in the context of inflammation and cardiovascular disease, loss of TRIB3 has been implicated in the development of diabetic atherosclerosis ameliorating insulin resistance and reducing macrophage apoptosis via modulating AKT phosphorylation (34, 35). Here, AKT1 is linked to cardiovascular disorder.